Ngā hua rapu - Deborah Lloyd
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
-
2
A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection mā Ching‐Lung Lai, Seng Gee Lim, Nathaniel Brown, Xiao‐Jian Zhou, Deborah Lloyd, Yin-Mei Lee, Man‐Fung Yuen, George Chao, Maureen Myers
I whakaputaina 2004Artigo -
3
A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B mā Ching‐Lung Lai, Nancy Leung, Eng Kiong Teo, Myron J. Tong, Florence Wong, Hie‐Won Hann, Steven Han, Thierry Poynard, Maureen Myers, George Chao, Deborah Lloyd, Nathaniel Brown
I whakaputaina 2005Artigo -
4
Mutations in Multidomain Protein MEGF8 Identify a Carpenter Syndrome Subtype Associated with Defective Lateralization mā Stephen R.F. Twigg, Deborah Lloyd, Dagan Jenkins, Nursel E. Elçioglu, C.D.O. Cooper, Nouriya Al‐Sannaa, Alı Annagür, Gabriele Gillessen‐Kaesbach, Irina Hüning, Samantha J.L. Knight, Judith A. Goodship, Bernard Keavney, Philip L. Beales, O. Gileadi, Simon J. McGowan, Andrew O.M. Wilkie
I whakaputaina 2012Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Adverse effect
Biology
Gastroenterology
Genetics
HBeAg
HBsAg
Hepatitis B
Hepatitis B virus
Immunology
Internal medicine
Lamivudine
Medicine
Neuroscience
Telbivudine
Tolerability
Virology
Virus
Adaptation (eye)
Botany
Computational biology
Demography
Dosing
Ecology
Evolutionary biology
Gene
Gene flow
Genetic variation
Hybrid
Hybrid zone
Lateralization of brain function